EPI-PHARE participates in the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, in Philadephie (USA)

During this congress, EPI-PHARE presents 3 posters :

• Impact of Levothyrox formulation change on health and healthcare use in France.
• Risk of Hematologic Malignant Neoplasms after post-operative treatment of Breast Cancer
• Potential inappropriate underdosing in patients initiating non-vitamin K oral anticoagulants in France: findings from the national healthcare databases